Diabetes slows long COVID recovery and harms heart health By Jeronimo Santos
3 min read
 |
Diabetic patients infected with COVID-19 endure a slower rehabilitation process, suffer elevated post-acute medical problems and require extended clinical surveillance. An investigation conducted by Universidade de São Paulo tracked 870 individuals for seven months following their hospital discharge to verify these lasting health deficits.
“Diabetes is not merely a risk factor during the acute phase of COVID-19, but an element that extends recovery duration and degrades quality of life over the long term, creating an urgent demand for specialized care to prevent repeated hospitalizations,” stated Maria Elizabeth Rossi da Silva, head of the Diabetes Unit at Hospital das Clínicas da Universidade de São Paulo and co-author of the paper published in Scientific Reports.
The clinical evaluation confirmed that individuals with metabolic illness faced greater chances of cardiovascular events including myocardial infarction and angina pectoris compared to non-diabetic subjects. Physical fragility increased markedly seven months after discharge, producing more frequent falls, physical impairments and reduced cognitive capacities.
Hospital evaluations during the initial pandemic surge
The research compared 320 individuals diagnosed with diabetes against 550 patients without the metabolic disorder as part of a wider investigation supported by FAPESP that monitored more than 3,000 people admitted to Hospital das Clínicas between March and September of 2020.
Participants completed detailed physical and laboratory examinations approximately seven months after leaving the wards. Specialists conducted all testing sessions in person to measure residual systemic damage.
Full recovery reached 94.3% among individuals without the metabolic condition, whereas the proportion dropped to 89.8% in diabetic survivors. The gap is considerable. Silva reported this numerical disparity directly.
The pathogen exerts immense physiological pressure on the circulatory system of diabetic individuals. “Systemic inflammation caused by diabetes combines with the direct toxicity of the virus, turning the heart into a primary target for serious complications, and that danger escalates alongside the total count of co-occurring illnesses,” Silva explained.
The resulting damage destabilizes physical function across the entire cohort. Within the diabetic segment, 21.1% of patients reported falling down after their hospital release. Non-diabetic participants registered an incidence rate of 11.1% for identical accidents.
“The combination of disrupted metabolism and longer inpatient stays, which averaged 16 days for diabetic patients versus 13 days for others, drives muscle loss that restricts basic daily autonomy,” Silva stated.
Socioeconomic hurdles and biological factors both require integration into post-discharge routines. Silva explained that persistent inflammation, metabolic deterioration, accelerated arterial strain and direct viral disruption of pancreatic tissue or insulin sensitivity collectively leave these individuals highly susceptible to recurring medical crises.
Unequal living conditions worsen overall medical prognosis through poor nutrition, barriers to diagnostic centers, lack of exercise and elevated psychological strain. Silva argued that national health services must design continuous protocols focused exclusively on managing post-viral metabolic recovery. Targeted outpatient programs remain critical for reducing chronic morbidity.
The medical screening also determined that 7.3% of previously healthy individuals developed diabetes following their viral infection. Silva noted that while direct viral injury to pancreatic cells remains plausible, severe inflammatory shocks likely unmasked latent conditions or triggered clinical disease in genetically predisposed subjects.
“Pandemic lifestyle disruptions such as prolonged domestic confinement, poor nutrition, physical inactivity, obesity and emotional distress may have catalyzed metabolic dysfunction,” Silva noted.
Researchers at Hospital das Clínicas are now analyzing patient data collected three years after the initial viral contraction. Silva indicated that ongoing laboratory work will outline the multi-year trajectory of the disease.
